Irinotecan (CPT 11)

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
40012
Randomised Phase III Intergroup Trial in Resected Stage 2 (Dukes B) Colon Cancer : 6-month Infusional 5FU-CPT11 (+/- Folinic Acid) versus Observation. Determination of Biologic Predictive and Response Factors (PETACC-4).
30992
Phase II study of Irinotecan (CPT 11) and Cisplatin (CDDP) in metastatic or locally advanced penile carcinoma.
40015
Irinotecan combined with infusional 5-FU/Folinic acid or Capecitabine and the role of Celecoxib in patients with metastatic colorectal cancer
05011
Time finding study of chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as first or second chemotherapy line against metastatic colorectal cancer.

Back to Protocol section